DAIICHI SANKYO, INC. for DAIICHI SANKYO INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Discussions regarding the Omnibus Spending Bill (H.R.1 - PL 115-97)
Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LANCE GILGORE | — |
Medicare/Medicaid MMM
Discussions regarding Medicare, IPAB, and Part D and Part B
Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LANCE GILGORE | — |
Pharmacy PHA
Discussions regarding opioid abuse Discussions regarding 340B drug discount program Food & Drug Cosmetics Act Drug pricing
Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LANCE GILGORE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.